AMLX Amylyx Pharmaceuticals, Inc.
Healthcare$13.68+0.74%ClosedMarket Cap: $1.14B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$24.50
Target (Median)
$24.50
Target Range
$21.00 - $28.00
Upside from current price: 79.1%
Rating Distribution
0 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-28 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-19 | Guggenheim | maintain | Buy | Buy |
| 2026-02-20 | B of A Securities | maintain | Buy | Buy |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-07 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-17 | Citigroup | maintain | Buy | Buy |
| 2025-10-16 | Baird | maintain | Outperform | Outperform |
| 2025-10-03 | B of A Securities | maintain | Buy | Buy |
| 2025-09-16 | Goldman Sachs | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.27 | $44.7M | 7 |
| Sun Dec 31 | $-0.57 | $153.2M | 6 |
| Mon Dec 31 | $0.59 | $321.4M | 4 |
| Tue Dec 31 | $1.94 | $538.3M | 2 |